# FDA Inspection 902528 - Berger, Daniel  M.D. - December 04, 2014

Source: https://www.keypedia.com/records/fda_inspections/berger-daniel-md/4ecb0e35-8eb2-41cb-9b0f-cf3c62e35f31
Source feed: FDA_Inspections

> FDA Inspection 902528 for Berger, Daniel  M.D. on December 04, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 902528
- Company Name: Berger, Daniel  M.D.
- Inspection Date: 2014-12-04
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 996685 - 2016-11-15](https://www.keypedia.com/records/fda_inspections/berger-daniel-md/45d658e2-2204-4c95-810c-504af4772840)
- [FDA Inspection 638294 - 2009-11-24](https://www.keypedia.com/records/fda_inspections/berger-daniel-md/a04a864c-c7da-423e-a6d3-938d525f3d1b)
- [FDA Inspection 583659 - 2009-05-13](https://www.keypedia.com/records/fda_inspections/berger-daniel-md/e3ee9e35-e0a0-4260-9813-270e093fe028)

Company: https://www.keypedia.com/companies/berger-daniel-md/dea74c20-80ec-41ee-a1f1-34cdb0399b2a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c